HAIKOU CITY, China, Aug. 1, 2013 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans to hold its second quarter of year 2013 earnings conference call on Thursday, August 15, 2013 at 8:30 a.m. ET.
Listeners may access the call by dialing 1-866-519-4004 or 65-672-393-81 for international callers, Conference ID # 25773315. A webcast will also be available through CPHI's website at http://www.chinapharmaholdings.com. A replay of the call will be accessible through August 23, 2013 by dialing 1-855-452-5696 or 61-281-990-299 for international callers, Conference ID # 25773315.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a rapidly growing specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high-margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com. The Company routinely posts important information on its website.
Diana Huang
Phone: +86-898-66811730
Cell: +86-139-7660-0053
E-mail: hps@chinapharmaholdings.com
SOURCE China Pharma Holdings, Inc.
